Posts by: Diana Campelo Delgado

Diana Campelo Delgado

Diana holds a PhD in Biomedical Sciences, with specialization in genetics, from Universidade Nova de Lisboa, Portugal. Her work has been focused on enzyme function, human genetics and drug metabolism.

February 4, 2021February 4, 2021

Dosing Begins in Phase 1 Trial of FT-7051 for Advanced, Resistant Cancer

News

Dosing has begun in a Phase 1 clinical trial testing Forma Therapeutics’ investigational therapy FT-7051 in people with metastatic castration-resistant prostate cancer (mCRPC). Recruiting at sites in Arizona and South Carolina, ... Read more

January 26, 2021January 26, 2021

EPI-7386 Combo Therapies Enter Trial for Certain mCRPC Patients

News

Essa Pharma has entered a clinical collaboration with Janssen to evaluate its small molecule inhibitor EPI-7386, in combination with either Erleada (apalutamide) or Zytiga (abiraterone acetate) plus prednisone, for patients with ... Read more

January 12, 2021January 12, 2021

Orgovyx Now Available in US for Advanced Prostate Cancer

News

A couple of weeks after its approval, Orgovyx (relugolix) is now commercially available in the U.S. for adults with advanced prostate cancer through authorized specialty distributors, the therapy’s developer, Myovant ... Read more

December 17, 2020December 17, 2020

Teams Working in Advanced Cancer Win 2020 PCF Challenge Awards

News

The philanthropic organization Prostate Cancer Foundation (PCF) and the charity Movember Foundation have announced the winners of the 2020 PCF Challenge Awards, an initiative that supports promising research in the ... Read more